CD4 T cell differentiation and regulation in autoimmune diabetes
In plain English
AI plain-English summaryA particular subset of immune cells—follicular helper T cells—has been identified as the likely culprit behind type 1 diabetes in mice. This matters because current treatments for type 1 diabetes suppress the entire immune system, leaving patients vulnerable to infections and other side effects. The disease occurs when immune cells attack the pancreas, destroying insulin production. Even transplanted insulin-producing cells get destroyed. Until now, researchers did not know which specific immune cells drive the attack, making targeted treatment impossible. This project pinpoints follicular helper T cells as the key players. If this research succeeds, it could lead to therapies that selectively eliminate or block only these disease-causing cells, leaving the rest of the immune system intact. The team will first confirm whether the same cell type appears in blood samples from human patients, then test whether targeting these cells can prevent or reverse diabetes in mouse models. A successful outcome would shift treatment from blanket immune suppression to precision targeting—a change that could dramatically reduce side effects for people living with type 1 diabetes.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
FellowshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know